National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/07-401"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "07-401"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2007-01-31"
last_updated: "2007-01-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
document_number: "07-401"
document_type: "notice"
publication_date: "2007-01-31"
agencies:
  - "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
  - "National Institutes of Health"
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, February 27, 2007, 12 p.m. to February 27, 2007, 4 p.m., National Institutes of Health, 6130 Executive Blvd., Rockville, MD 20852 which was published in the *Federal Register* on December 28, 2006, 71 FR 78214.

The meeting notice is changed to reflect the change in the name of the committee from “SBIR Topic 230 (Phases I & II)” to “SBIR, Synthesis Stable Isotope-Labeled Steroids as Internal Standards.” The meeting is closed to the public.

Dated: January 23, 2007.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.